Interview Series 2nd April 2026
From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon
In this episode of From the helm, Sophia Mavridis is joined by Centaurus Metals (ASX:CTM) CEO & MD Darren Gordon to discuss what sets their product apart from its peers and what is next for the broader nickel market.
-
_600_338.png)
Interview Series 2 Apr 2026
From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter
-
_600_338.png)
Interview Series 1 Apr 2026
From the helm: Titomic Ltd, CFO, Geoff Hollis
-
_600_338.png)
Interview Series 1 Apr 2026
From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder
-
_600_338.png)
Interview Series 1 Apr 2026
From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO
-
_600_338.png)
Market wraps 31 Mar 2026
Navigating geopolitical turbulence:The strategic case for defence technology
-
_(1)_600_338.png)
Market wraps 27 Mar 2026
Weekly Wrap 27 March
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.